Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tibremciclib |
Trade Name | |
Synonyms | BPI-16350|BPI16350|BPI 16350 |
Drug Descriptions |
Tibremciclib inhibits CDK4/6, potentially resulting in antitumor activity (Ann Oncol (2024) 35 (suppl_2): S349). |
DrugClasses | CDK4/6 Inhibitor 14 |
CAS Registry Number | 2397678-18-9 |
NCIT ID | C203165 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + Tibremciclib | Fulvestrant Tibremciclib | 0 | 0 |
Tibremciclib | Tibremciclib | 0 | 0 |